|
|||||
|
|
Azacitidine access program for Belgian patients with myelodysplastic syndromes,acute myeloid leukemia or chronic myelomonocytic leukemia |
|
| Authors: | S Meers D Selleslag H Potier A Glasmacher P Mineur |
| Institution: | 1. AZ Klina, Brasschaat, Belgium;2. AZ Sint-Jan, Brugge-Oostende, Belgium;3. Celgene International, Boudry, Switzerland;4. Grand Hopital de Charleroi (GHdC), Charleroi, Belgium |
| Abstract: | |
| Keywords: | Azacitidine Belgium Myelodysplastic syndromes Reimbursement |